Aemetis, Inc AMTX

FY2025 · ended Dec 31, 2025 · Revenue $197.63M, -26.2% YoY · Filed Mar 16, 2026

Aemetis, Inc (AMTX) files with the SEC under industry code 2860, Industrial Organic Chemicals. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $197.6 million and a net loss of $77.0 million. Free cash flow was -$22.7 million. As of Sep 30, 2026 it held $3.4 million in cash and investments and $502.5 million in total debt.

Revenue (TTM)
$248.78M
+23.6% vs year-ago TTM
Net income (TTM)
$-31.20M
+64.5% vs year-ago TTM
Operating cash flow (TTM)
$15.29M
+201.3% vs year-ago TTM
Free cash flow (TTM)
$-36.58M
-16.8% vs year-ago TTM
EPS (TTM)
$-0.45
+71.2% vs year-ago TTM
Dividend per share
None
Shares outstanding
66.63M
+25.0% vs prior year
Net cash
$-499.19M
as of Sep 30, 2026
Operating margin
7.2%
FY 2026

Company profile

Industry
Industrial Organic Chemicals (SIC 2860)
Listed as
AMTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Cupertino, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
738214
Former names
AE Biofuels, Inc. (until Nov 16, 2011); AE BIOFUELS, INC. (until Nov 16, 2011); MARWICH II LTD (until Dec 11, 2007)

Other Industrial Organic Chemicals companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$197.6M
$267.6M
$186.7M
$256.5M
$211.9M
Operating income
-$37.2M
-$40.4M
-$37.4M
-$34.4M
-$15.8M
Net income
-$77.0M
-$87.5M
-$46.4M
-$107.8M
-$47.1M
Diluted EPS
-$1.28
-$1.91
-$1.22
-$3.12
-$1.54
Operating cash flow
$3.3M
-$32.9M
$13.8M
-$22.9M
-$20.6M
Free cash flow
-$22.7M
-$53.2M
-$19.3M
-$62.0M
-$47.3M
Total assets
$259.8M
$259.3M
$243.4M
$207.1M
$160.8M
Stockholders' equity
-$306.8M
-$263.9M
-$217.0M
-$201.9M
-$120.2M
Cash and investments
$4.9M
$898,000
$2.7M
$4.3M
$7.8M
Total debt
$425.9M
$370.1M
$323.1M
$288.5M
$208.1M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2026 Aug 6, 2026
8-K Current report
Shareholder vote results
May 26, 2026 May 20, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.